Log in
ETR:MDG1

Medigene AG (MDG1.F) Stock Forecast, Price & News

€3.70
-0.04 (-1.07 %)
(As of 11/26/2020 12:00 AM ET)
Add
Compare
Today's Range
€3.56
Now: €3.70
€3.75
50-Day Range
€3.30
MA: €3.59
€3.90
52-Week Range
€2.91
Now: €3.70
€7.19
Volume75,577 shs
Average Volume306,207 shs
Market Capitalization$90.88 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Medigene AG, a clinical stage immuno-oncology company, focuses on the development of T cell immunotherapies for the treatment of cancer. The company operates in two segments, Immunotherapies and Other products. It is developing personalized T cell-based therapies, with a focus on T cell receptor-modified T cells and associated projects, which are in pre-clinical and clinical development. It also focuses on DC vaccines and T cell-specific monoclonal antibodies. In addition, the company focuses on developing and marketing RhuDex for hepatology and gastroenterology indications. Medigene AG has a strategic partnership with bluebird bio, Inc. for the development of T cell receptors. The company also has research collaboration agreements on novel cancer antigens for immunotherapies with the Université de Montréal and Institute for Research in Immunology and Cancer  Commercialization of Research, Canada; and with Cytovant Sciences Co. Ltd. and PHIO Pharmaceuticals Corp. It has operations in Europe, the United States, Greater China, and internationally. The company was founded in 1994 and is headquartered in Munich, Germany.
Read More
Medigene AG (MDG1.F) logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+49-89-2000330
Employees123

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$8.57 million
Cash Flow€1.59 per share
Book Value€2.82 per share

Profitability

Miscellaneous

Market Cap$90.88 million
Next Earnings DateN/A
OptionableNot Optionable
€3.70
-0.04 (-1.07 %)
(As of 11/26/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MDG1 News and Ratings via Email

Sign-up to receive the latest news and ratings for MDG1 and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Medigene AG (MDG1.F) (ETR:MDG1) Frequently Asked Questions

How has Medigene AG (MDG1.F)'s stock price been impacted by Coronavirus?

Medigene AG (MDG1.F)'s stock was trading at €4.16 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, MDG1 stock has decreased by 11.0% and is now trading at €3.70.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Medigene AG (MDG1.F)?

Wall Street analysts have given Medigene AG (MDG1.F) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Medigene AG (MDG1.F) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Medigene AG (MDG1.F)'s key competitors?

What other stocks do shareholders of Medigene AG (MDG1.F) own?

Who are Medigene AG (MDG1.F)'s key executives?

Medigene AG (MDG1.F)'s management team includes the following people:
  • Dr. Dolores J. Schendel, CEO, Chief Scientific Officer & Member of Exec. Management Board
  • Dr. Horst Domdey, Co-Founder & Member of the Supervisory Board (Age 69, Pay $33k)
  • Mr. Axel Sven Malkomes, CFO, Chief Bus. Devel. Officer & Member of Exec. Management Board
  • Dr. Kai Pinkernell, Chief Medical Officer, Chief Devel. Officer & Member of Exec. Management Board
  • Dr. Ernst-Ludwig Winnacker, Co-Founder & Chairman Scientific Advisory Board (Age 79)
  • Dr. Gary Anthony Waanders Ph.D., VP of Investor Relations

What is Medigene AG (MDG1.F)'s stock symbol?

Medigene AG (MDG1.F) trades on the ETR under the ticker symbol "MDG1."

What is Medigene AG (MDG1.F)'s stock price today?

One share of MDG1 stock can currently be purchased for approximately €3.70.

How big of a company is Medigene AG (MDG1.F)?

Medigene AG (MDG1.F) has a market capitalization of $90.88 million and generates $8.57 million in revenue each year. Medigene AG (MDG1.F) employs 123 workers across the globe.

What is Medigene AG (MDG1.F)'s official website?

The official website for Medigene AG (MDG1.F) is www.medigene.de.

How can I contact Medigene AG (MDG1.F)?

Medigene AG (MDG1.F)'s mailing address is Lochhamer Strasse 11, PLANEGG, 82152, Germany. The company can be reached via phone at +49-89-2000330.

This page was last updated on 11/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.